Micin
Tokyo, JP · 3 known investors
MICIN Inc. is a Japanese company operating in healthcare, publishing disclosures about funding provided to medical institutions in line with industry transparency guidelines. This page is a regulatory/transparency disclosure rather than a product description.
Also known as MICIN · MICIN Inc. · 株式会社MICIN
Founders & leadership
Investors · 3
.png){kind=logo}
Company profile
researched Aug 2026MICIN Inc. (株式会社MICIN) is a Tokyo-based healthcare technology company that states a mission of making medical care more accessible and simple and of creating new life choices from health and medical data. Its stated vision is a world in which everyone can live and reach the end of life with a sense of acceptance.
The company operates four business lines. The Medical Experience business connects patients with physicians and pharmacists online and improves the convenience of clinic visits: curon online consultation (launched April 2016) handles booking, questionnaires, consultation, payment and medication delivery arrangements for in-clinic dispensing on a patient's own smartphone, PC or tablet, and requires no setup or monthly fee from physicians; curon Okusuri Support (released May 2020) provides pharmacies with online medication guidance plus credit-card settlement and delivery support; and curon Smart Pass is a cashless payment service that lets patients complete reception, billing and medicine pickup with a smartphone, leaving the clinic with a prescription without waiting for checkout and receiving dispensing-complete notifications by LINE or email, with no installation fee, monthly fee or card processing fee for medical institutions. The MiROHA clinical development digital solutions business supplies online consultation for clinical trials, eConsent for electronic informed consent, and eSource for digitizing trial data at sites and sponsors. The digital therapeutics business develops evidence-based software interventions for prevention, diagnosis, treatment and disease management, including MedBridge, a system supporting patient self-care habits and channeling subjective and objective patient data to doctors and nurses. The insurance business is conducted through subsidiary MICIN Small Amount and Short Term Insurance Co., Ltd.
MICIN's leadership includes founder and CEO Seigo Hara, a physician and University of Tokyo School of Medicine graduate with a Stanford MBA who previously worked at McKinsey, served in the Ministry of Health, Labour and Welfare's "Health Care 2035" secretariat, and is a part-time lecturer at Yokohama City University School of Medicine. The board includes director Maria Seo (ex-Goldman Sachs investment banking), outside director Naoaki Mashita (founder of V-cube and Sensyn Robotics), and outside auditors Yoshihide Todoroki (CPA), Mariko Mimura (attorney) and Kazuomi Kaneto. Kiyoshi Kurokawa, representative director of the Health and Global Policy Institute and professor emeritus at the University of Tokyo, is listed as a supporter.
Founding story
The company was founded by Seigo Hara, a physician who graduated from the University of Tokyo School of Medicine and worked at McKinsey before starting MICIN; he also worked in the Ministry of Health, Labour and Welfare's "Health Care 2035" secretariat on policy recommendations for Japanese healthcare in 2035 and holds a Stanford MBA.
Business model
MICIN sells and operates software services across four segments: patient-facing and provider-facing online care and cashless payment services (curon, curon Okusuri Support, curon Smart Pass), clinical development digital solutions for trial sponsors and sites (MiROHA online consultation, eConsent, eSource), digital therapeutics software (MedBridge and a jointly developed IBS therapeutic app), and insurance underwriting through MICIN Small Amount and Short Term Insurance. Several provider-side services are offered without installation fees, monthly fees or card settlement fees.
Latest developments
Recent activity includes an August 2025 agreement to jointly develop and sell a therapeutic app for irritable bowel syndrome; the December 2025 launch of obesity-focused online consultation services Obinavi and Slimaru covering insured and self-pay care; Nippon Life's March 2026 adoption of curon as an ancillary service to a new medical insurance product from 2 April; the June 2026 integration of curon Okusuri Support with the Yakushimaru Kenta AI-OCR at Kusuri no Fukutaro pharmacies in the Tokyo area; the July 2026 waiver of online consultation fees for Kumamoto Prefecture residents; and an August 2026 survey of 500 people with BMI of 25 or above reporting that about 30% may have obesity requiring treatment and that about 90% of those had no experience of physician-guided weight loss.
▸Full profile — market position, technology, go-to-market, geography
Market position
MICIN participates in Japan's digital health sector, is a member of the Japan Digital Health Alliance and the Impact Startup Association, and its CEO serves as a director of the Japan Medical Venture Association. Its services have been featured on national broadcasters and in outlets including Nikkei, Nikkan Kogyo Shimbun, Chiba Nippo and WIRED.
Technology
The product portfolio is software-based: browser and app-based online consultation and medication-guidance tools usable on consumer smartphones, PCs and tablets; electronic informed consent and electronic source data capture for clinical trials; cashless payment and notification workflows integrated with LINE and email; and evidence-based digital therapeutics that collect patient-reported and objective data for clinicians. In 2026 curon Okusuri Support was integrated with a high-accuracy AI-OCR system.
Go-to-market
MICIN distributes through medical institutions and pharmacies that adopt its services at no installation or monthly cost, through partnerships with pharmaceutical companies and cancer centers for trial deployments, through insurer tie-ups such as the Nippon Life medical insurance ancillary service, and through public-sector and regional initiatives such as waiving online consultation fees for Kumamoto Prefecture residents. It also publishes survey releases and Digital Health Times content, and its CEO appears in national media and policy forums.
Patients seeking remote or streamlined access to care, medical institutions and clinics, pharmacies and pharmacists, pharmaceutical companies and clinical trial sites conducting decentralized trials, insurers and insurance policyholders.
Geography
Headquartered in Tokyo, Japan, with services deployed at Japanese medical institutions and pharmacies, including metropolitan Tokyo-area pharmacy chains and regional programs such as Kumamoto Prefecture; the company announced an office relocation in December 2024.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 11
launches, deals, and filingsThe pharmacy online medication guidance service was linked with the high-accuracy AI-OCR system “Yakushimaru Kenta” and put into operation at Kusuri no Fukutaro pharmacies in the Tokyo metropolitan area.
From 2 April, curon online consultation is offered as an attached service to Nippon Life's new medical insurance, with the usage fee waived three times a year.
Full launch of online medical consultation for patients with obesity via two offerings, Obinavi and Slimaru, covering both insured and self-pay treatment needs.
Aichi Cancer Center, St. Marianna University Hospital and MICIN implemented what the company describes as Japan's first fully remote online clinical trial using an injectable investigational drug in the oncology field.
Deployment of MICIN's MiROHA eConsent in a company-sponsored oncology clinical trial to advance decentralized clinical trials (DCT) in the cancer field.
Released an online medication guidance service for pharmacies, initially as a COVID-19 response, providing credit card payment and delivery support to reduce uncollected-payment risk and delivery burden when pharmacists give guidance by phone or video call.
MICIN began offering curon (クロン), an online medical consultation service that lets patients complete booking, questionnaire, consultation, payment and medication delivery arrangements (for in-clinic dispensing) via smartphone, PC or tablet, with no initial or monthly fee for physicians.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- Micinmicin.jp · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Micin do?
- Japanese digital health company offering online medical consultation, clinical-trial software, digital therapeutics and insurance.
- Who founded Micin?
- Micin was founded by 原 聖吾, Ryoichi Kusama.
- Who are Micin's investors?
- Micin's investors include DG Daiwa Ventures, Sony Ventures Corporation, Aozora Corporate Investment.
- Where is Micin headquartered?
- Micin is headquartered in Tokyo, JP.